폐외결핵 환자에서의 치료에 따른 연속적인 T-SPOT.TB 검사
Serial Testing of T-SPOT.TB Assays with Anti-Tuberculosis Therapy in Patients with Extrapulmonay Tuberculosis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Limited data are available for the clinical utility of serial interferongamma producing T-cell response after initiation of treatment in patients with extrapulmonary tuberculosis (TB). We studied the serial TB-specific antigen T-cell responses measured using the T-SPOT.TB assay during the course of therapy. Material and Methods: We prospectively enrolled adult patients who were newly diagnosed with active extrapulmonary TB over a 24-month period. All patients were given standard anti-TB treatment. Blood samples were obtained for T-SPOT.TB at diagnosis, as well as 1-, 3-, 6-, and 12-months after initiating anti-TB therapy. Results: A total of 52 patients with extrapulmonary TB (38 confirmed and 14 probable TB) were included in the final analysis. All patients had clinical and radiologic improvement after treatment and cured. T-SPOT.TB was positive for 90% at diagnosis, 100% at 1-, 3-, and 6-months, and 93% at 12-months after initiation of anti-TB therapy. There was no significant difference in median T-cell response between early secreting antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-10) at all time points. Median T-cell response steadily increased up to 6 months and then decreased. Conclusions: T-SPOT.TB assay remained positive after successful anti-TB treatment in most patients with extrapulmonary TB. Our data suggests that serial T-SPOT.TB has limited clinical utility as a surrogate marker of treatment response in patients with extrapulmonary TB.
Abstract
Background: Limited data are available for the clinical utility of serial interferongamma producing T-cell response after initiation of treatment in patients with extrapulmonary tuberculosis (TB). We studied the serial TB-specific antigen T-cell responses measured using the T-SPOT.TB assay during the course of therapy. Material and Methods: We prospectively enrolled adult patients who were newly diagnosed with active extrapulmonary TB over a 24-month period. All patients were given standard anti-TB treatment. Blood samples were obtained for T-SPOT.TB at diagnosis, as well as 1-, 3-, 6-, and 12-months after initiating anti-TB therapy. Results: A total of 52 patients with extrapulmonary TB (38 confirmed and 14 probable TB) were included in the final analysis. All patients had clinical and radiologic improvement after treatment and cured. T-SPOT.TB was positive for 90% at diagnosis, 100% at 1-, 3-, and 6-months, and 93% at 12-months after initiation of anti-TB therapy. There was no significant difference in median T-cell response between early secreting antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-10) at all time points. Median T-cell response steadily increased up to 6 months and then decreased. Conclusions: T-SPOT.TB assay remained positive after successful anti-TB treatment in most patients with extrapulmonary TB. Our data suggests that serial T-SPOT.TB has limited clinical utility as a surrogate marker of treatment response in patients with extrapulmonary TB.
참고문헌 (33)
- "Tuberculosis profile: Republic of Korea"[URL]
- Pai M, "Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review", Lancet Infect Dis, 4, pp.761~776 (2004)
- Kim SH, "Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis", Arch Intern Med, 167, pp.2255~2259 (2007)
- "Diagnostic Usefulness of a T-cell-based Assay for Extrapulmonary Tuberculosis in Immunocompromised Patients", AMERICAN JOURNAL OF MEDICINE, 122(2), pp.189~195
- Doherty TM, "Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients", J Clin Microbiol, 40, pp.704~706 (2002)
- Vordermeier HM, "Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis", Infect Immun, 70, pp.3026~3032 (2002)
- Lee SW, "Serial interferon-gamma release assays during treatment of active tuberculosis in young adults", BMC INFECTIOUS DISEASES, 10, pp.300~ (2010), BIOMED CENTRAL LTD
- Pai M, "Sensitivity of a whole-blood interferon- gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during antituberculosis treatment", Infection, 35, pp.98~103 (2007)
- Aiken AM, "Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases", BMC Infect Dis, 6, pp.66~ (2006)
- Kobashi Y, "Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment", J Infect, 58, pp.197~204 (2009)
- Katiyar SK, "Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis", Int J Tuberc Lung Dis, 12, pp.1146~1152 (2008)
- Carrara S, "Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy", Clin Infect Dis, 38, pp.754~756 (2004)
- Chee CB, "Tuberculosis treatment effect on T-cell interferon- gamma responses to Mycobacterium tuberculosisspecific antigens", Eur Respir J, 36, pp.355~361 (2010)
- Dheda K, "Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results", J Infect, 55, pp.169~173 (2007)
- Domínguez J, "T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment", Diagn Microbiol Infect Dis, 63, pp.43~51 (2009)
- Blumberg HM, "American Thoracic Society", Centers for Disease Control and Prevention, Am J Respir Crit Care Med, pp.2003, 167[DOI]
- Liebeschuetz S, "Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study", Lancet, 364, pp.2196~2203 (2004)
- Kim SH, "Diagnosis of abdominal tuberculosis by T-cell-based assays on peripheral blood and peritoneal fluid mononuclear cells", J Infect, 59, pp.409~415 (2009)
- Cho OH, "Diagnostic usefulness of a T-cell-based assay for osteoarticular tuberculosis", J Infect, 61, pp.228~234 (2010)
- Kim SH, "Rapid Diagnosis of Tuberculous Meningitis by T Cell-Based Assays on Peripheral Blood and Cerebrospinal Fluid Mononuclear Cells", CLINICAL INFECTIOUS DISEASES, 50(10), pp.1349~1358 (2010), UNIV CHICAGO PRESS
- Lalvani A, "Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians", J Infect Dis, 183, pp.469~477 (2001)
- Adetifa IM, "Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases", PLoS One, 5, pp.e12502~ (2010)
- Pathan AA, "Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment", J Immunol, 167, pp.5217~5225 (2001)
- Herrmann JL, "Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis", PLoS One, 4, pp.e4130~ (2009)
- Nicol MP, "Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy", Clin Infect Dis, 40, pp.1301~1308 (2005)
- Cheng SL, "Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis", Int J Tuberc Lung Dis, 11, pp.1290~1295 (2007)
- van Zyl-Smit RN, "Withinsubject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing", Am J Respir Crit Care Med, 180, pp.49~58 (2009)
- Naseer A, "Evidence for boosting Mycobacterium tuberculosis-specific IFN-gamma responses at 6 weeks following tuberculin skin testing", Eur Respir J, 29, pp.1282~1283 (2007)
- Igari H, "Booster phenomenon of QuantiFERON-TB Gold after prior intradermal PPD injection", Int J Tuberc Lung Dis, 11, pp.788~791 (2007)
- Vilaplana C, "The tuberculin skin test increases the responses measured by T cell interferongamma release assays", Scand J Immunol, 67, pp.610~617 (2008)
- Richeldi L, "Repeated tuberculin testing does not induce false positive ELISPOT results", Thorax, 61, pp.180~ (2006)
- Leyten EM, "Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay", Eur Respir J, 29, pp.1212~1216 (2007)
- Nguyen M, "QuantiFERON-TB predicts tuberculin skin test boosting in U.S. foreign-born", Int J Tuberc Lung Dis, 9, pp.985~991 (2005)